Nanomedicines consisting of nanoparticles for targeted drug
delivery to specific tissues and cells offer new solutions for cancer diagnosis
and therapy. Understanding the interdependency of physiochemical properties of
nanomedicines, in correlation to their biological responses and functions, is
crucial for their further development of as cancer-fighters.